Table of Contents Author Guidelines Submit a Manuscript
Retraction
Research Article
Disease Markers
Volume 2015 (2015), Article ID 538785, 2 pages
http://dx.doi.org/10.1155/2015/538785
Letter to the Editor

Comment on “System Accuracy Evaluation of the GlucoRx Nexus Voice TD-4280 Blood Glucose Monitoring System”

GlucoRx Ltd., 4 Wintonlea, Monument Way West, Woking, Surrey GU21 5EN, UK

Received 18 February 2015; Accepted 8 March 2015

Academic Editor: Vincent Sapin

Copyright © 2015 Nilesh Nathwani. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Khan, K. Broadbent, M. Morris, D. Ewins, and F. Joseph, “System accuracy evaluation of the GlucoRx Nexus Voice TD-4280 blood glucose monitoring system,” Disease Markers, vol. 2014, Article ID 602586, 8 pages, 2014. View at Publisher · View at Google Scholar
  2. J. Mahoney and J. Ellison, “Assessing the quality of glucose monitor studies: a critical evaluation of published reports,” Clinical Chemistry, vol. 53, no. 6, pp. 1122–1128, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. J. J. Mahoney and J. M. Ellison, “Assessing glucose monitor performance—a standardized approach,” Diabetes Technology and Therapeutics, vol. 9, no. 6, pp. 545–552, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. J. M. Baum, S. A. Pardo, H. C. Schachner, J. L. Parkes, and D. A. Simmons, “Re-evaluating a standard approach to assessing glucose monitor performance,” Diabetes Technology and Therapeutics, vol. 11, no. 5, pp. 323–325, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. G. H. Thorpe, “Assessing the quality of publications evaluating the accuracy of blood glucose monitoring systems,” Diabetes Technology and Therapeutics, vol. 15, no. 3, pp. 253–259, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. ISO, “In vitro diagnostic test systems—requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus,” ISO 15197:2003(E), International Standards Organization, Geneva, Switzerland, 2003. View at Google Scholar
  7. S. S. Ehrmeyer, R. H. Laessig, J. E. Leinweber, and J. J. Oryall, “1990 Medicare/CLIA final rules for proficiency testing: minimum intralaboratory performance characteristics (CV and bias) needed to pass,” Clinical Chemistry, vol. 36, no. 10, pp. 1736–1740, 1990. View at Google Scholar · View at Scopus
  8. D. B. Sacks, M. Arnold, G. L. Bakris et al., “Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus,” Clinical Chemistry, vol. 57, no. 6, pp. e1–e47, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. ISO 15197, In Vitro Diagnostic Test Systems—Requirements for Blood-Glucose Monitoring Systems for Self-Testing in Managing Diabetes Mellitus, ISO 15197, International Standards Organization, 2013.
  10. R. A. Sidebottom, P. R. Williams, and K. S. Kanarek, “Glucose determinations in plasma and serum: potential error related to increased hematocrit,” Clinical Chemistry, vol. 28, no. 1, pp. 190–192, 1982. View at Google Scholar · View at Scopus